A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity
CCAAT-Enhancer-Binding Protein-delta
0301 basic medicine
0303 health sciences
Carcinoma, Hepatocellular
Interleukin-6
CCAAT-Enhancer-Binding Protein-beta
Liver Neoplasms
Angiotensinogen
Kidney
Polymorphism, Single Nucleotide
Dexamethasone
Recombinant Proteins
3. Good health
03 medical and health sciences
Receptors, Glucocorticoid
Gene Expression Regulation
Hypertension
Mutation
CCAAT-Enhancer-Binding Proteins
Humans
Promoter Regions, Genetic
Glucocorticoids
Cells, Cultured
DNA Primers
DOI:
10.1007/s00109-004-0621-5
Publication Date:
2005-01-03T15:42:26Z
AUTHORS (4)
ABSTRACT
Hypertension is a serious health problem particularly for African-Americans. Previous studies have suggested that angiotensinogen (AGT) gene locus is involved in human essential hypertension. We have recently shown that an A/G polymorphism at -217 in the promoter of the AGT gene is associated with essential hypertension especially in African-Americans. We report here that A/G polymorphism at -217 affects the glucocorticoid-induced promoter activity of the human AGT gene. We show that recombinant glucocorticoid receptor (GR) binds strongly to the AGT gene promoter when nucleoside A is present at -217, and dexamethasone treatment increases the interleukin 6 induced promoter activity of reporter constructs containing nucleoside A at -217. Similarly cotransfection of GR and C/EBP beta or C/EBP delta increases the promoter activity of reporter construct containing nucleoside A at -217. Since AGT is an acute phase protein, we propose that increased expression of -217A allele of the AGT gene by glucocorticoids and C/EBP family of transcription factors may be involved in essential hypertension.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (30)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....